Kaiyuan Ni

机构：Takeda (United States) · ORCID：0000-0002-8152-6746

发表论文 81 篇 · 总被引 8589 次 · h-index 41

代表论文

• STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity (2022 · Nature Materials · 被引 335)
• Targeted modulation of immune cells and tissues using engineered biomaterials (2023 · Nature Reviews Bioengineering · 被引 157)
• Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity (2022 · Nature Biomedical Engineering · 被引 137)
• Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework (2022 · Nature Biomedical Engineering · 被引 107)
• Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy (2021 · Biomaterials · 被引 100)
• Surface engineered iron oxide nanozyme for synergistic chemodynamic/photodynamic therapy with glutathione depletion and hypoxia relief (2022 · Chemical Engineering Journal · 被引 60)